论文部分内容阅读
湖南省常德市洞庭制药厂,主要生产多种原料药和各类制剂成药。近年来,这个厂在竞争对手如云、医药市场疲软的困境中,以厂办科研所为基地,狠抓新产品开发承包,增加了产品储备,增强了企业的应变能力。“七五”期间,全厂共开发新产品60个,平均每年开发12个,其中主导厚利产品1个至2个。目前,这个厂的产品已由“六五”末期的5大类91个品种,发展到7大类167个品种,基本上做到了市场需要什么产品,什么产品有利可图,就开发和生产什么产品。企业连续5年保持了产值、销售、利润两
Dongting Pharmaceutical Factory, Changde City, Hunan Province, mainly produces various raw material medicines and various types of preparations. In recent years, this plant has been based on plant-run research institutes in the predicament of competitors such as the cloud and the pharmaceutical market. It has paid close attention to new product development contracts, increased product reserves, and enhanced the company’s resilience. During the “Seventh Five-Year Plan” period, a total of 60 new products were developed in the whole plant, with an average of 12 developments per year, of which one or two of the dominant heavy products were dominated. At present, the products of this plant have grown from the five major categories of 91 varieties at the end of the “6th Five-Year Plan” period to 7 categories of 167 varieties, basically achieving what products the market needs and what products are profitable to develop and produce. product. The company has maintained its output value, sales, and profit for five consecutive years